Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2016

Open Access 01-12-2016 | Letter

SEARCHBreast: a new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers

Authors: Bethny Morrissey, Karen Blyth, Phil Carter, Claude Chelala, Louise Jones, Ingunn Holen, Valerie Speirs

Published in: Breast Cancer Research | Issue 1/2016

Login to get access

Excerpt

Progress in understanding breast cancer biology is often underpinned by pre-clinical studies in mice. Upon completion of these studies, surplus tissues are frequently archived but often never used. There is a pressing need to make this material available so it can be shared with other research groups to answer additional scientific questions, saving time and cost by avoiding unnecessary animal models being created and, in many instances, duplicated. As well as increasing research outputs, this will reduce animal use, helping to address the 3Rs—Replacement, Refinement, and Reduction—in animal research [1]. …
Literature
1.
2.
Blyth K, Carter P, Morrissey B, Chelala C, Jones L, Holen I, et al. SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs. Breast Cancer Res Treat. 2016;156:447.CrossRefPubMedPubMedCentral
3.
Whittle JR, Lewis MT, Lindeman GJ, Visvader JE. Patient-derived xenograft models of breast cancer and their predictive power. Breast Cancer Res. 2015;17:17.CrossRefPubMedPubMedCentral
Metadata
Title
SEARCHBreast: a new online resource to make surplus material from in vivo models of breast cancer visible and accessible to researchers
Authors
Bethny Morrissey
Karen Blyth
Phil Carter
Claude Chelala
Louise Jones
Ingunn Holen
Valerie Speirs
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2016
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-016-0716-2

Other articles of this Issue 1/2016

Breast Cancer Research 1/2016 Go to the issue

Research article

COX-2 modulates mammary tumor progression in response to collagen density

Research article

Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment

Research article

A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions

Letter

Comment on: Tan WJ, Cima I, Choudhury Y, Wei X, Lim JCT, Thicke AA, Tan MH, Tan PH. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions. Breast Cancer Research 2016;18:31

Review

Cancer stem cell metabolism

Research article

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits